Home » Stocks » Cell Source

Cell Source, Inc. (CLCS)

Stock Price: $1.10 USD -0.27 (-19.71%)
Updated Aug 10, 2020 4:00 PM EDT - End of day

Stock Price Chart

Key Info

Market Cap 30.06M
Revenue (ttm) n/a
Net Income (ttm) -3.83M
Shares Out 27.33M
EPS (ttm) -0.16
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 10, 2020
Last Price $1.10
Previous Close $1.37
Change ($) -0.27
Change (%) -19.71%
Day's Open 1.39
Day's Range 1.10 - 1.50
Day's Volume 11,727
52-Week Range 0.41 - 1.56

More Stats

Market Cap 30.06M
Enterprise Value 33.10M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 27.33M
Float 18.00M
EPS (basic) -0.16
EPS (diluted) -0.16
FCF / Share -0.10
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta 0.64
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio n/a
Revenue n/a
Operating Income -3.37M
Net Income -3.83M
Free Cash Flow -2.80M
Net Cash -3.04M
Net Cash / Share -0.11
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -2,208.97%
ROE n/a
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$n/a*
*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013
Revenue-------
Operating Income-3.81-2.01-2.29-2.32-2.32-4.05-1.46
Net Income-4.48-2.12-3.08-0.97-2.50-4.06-1.78
Shares Outstanding28.3327.5526.7726.1925.7222.1913.17
Earnings Per Share-0.18-0.09-0.12-0.04-0.10-0.18-0.14
Operating Cash Flow-2.59-2.00-2.29-1.49-2.00-3.12-0.89
Capital Expenditures-------
Free Cash Flow-2.59-2.00-2.29-1.49-2.00-3.12-0.89
Cash & Equivalents0.030.020.370.000.010.020.03
Total Debt2.602.672.323.091.110.10-
Net Cash / Debt-2.57-2.65-1.95-3.08-1.11-0.080.03
Assets0.110.070.530.210.210.120.09
Liabilities5.864.995.096.455.973.910.79
Book Value-5.74-4.92-4.56-6.24-5.76-3.78-0.70
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Cell Source, Inc.
Country United States
Employees 1
CEO Itamar Shimrat

Stock Information

Ticker Symbol CLCS
Stock Exchange US OTC
Sector Healthcare
Industry Biotechnology
Unique Identifier OTCMKTS: CLCS

Description

Cell Source, Inc., a cell therapy company, focuses on developing and commercializing immunotherapy medicines in Israel. The company's lead product is the Veto Cell immune system management technology, which is an immune tolerance biotechnology that enables the selective blocking of immune responses. Its Veto Cell technology is used in various applications, such as treatment of lymphoma, leukemia, and multiple myeloma; and facilitating the stem cell transplantation acceptance, as well as treatment of end stage kidney disease and other non-malignant organ diseases, and various cancers and non-malignant diseases. The company was founded in 2011 and is headquartered in New York, New York.